Owing to the controlled or uncontrolled industrial wastewater disposal, pharmaceutical-based hazardous emerging contaminants (ECs) can be found in the environment all over the world. With ever-increasing socioeconomic aspects and environmental awareness, people are now more concerns about the widespread occurrences of hazardous and persistent contaminants, around the globe. In this context, several studies have already shown that various types of emerging and/or re-emerging contaminants, regardless the source, type and concentration, are of supreme threat to the living system of flora and fauna. Recently, algae-based bioreactors have gained special research interest as a promising way to remove pharmaceuticals-based ECs from the wastewater either partially or completely. This paper covers the progress on the removal of selected pharmaceuticals using bioreactors. In laboratory scale studies, high removal percentages have been reached for most selected pharmaceuticals, but data on full-scale bioreactors is limited. In this paper, two types of bioreactors are discussed, i.e., (1) open pond and (2) bubble column photobioreactor, which are considered sustainable and an effective alternative to remove ECs. In these bioreactors, high removal percentages (>90%) have been found for metoprolol, triclosan, and salicylic acid, moderate (50-90%) for carbamazepine and tramadol and very low (<10%) for trimethoprim and ciprofloxacin by inoculating different microalgae. This technique may open new opportunities for the treatment of wastewater and reduce the environmental pollution that can have adverse effects on the ecosystem and human health. In summary, the present review focuses on the microalgae for wastewater remediation. An effort has also been made to describe the generalities of the photobioreactor.
Keywords: Algae; Bioreactor; Emerging contaminants; Pharmaceuticals; Removal strategies; Wastewater.
Copyright © 2019 Elsevier B.V. All rights reserved.